TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Vitrafy Life Sciences Ltd. ( (AU:VFY) ) has provided an announcement.
Vitrafy Life Sciences Limited held its 2025 Annual General Meeting, where all resolutions presented to shareholders were carried, including the adoption of the remuneration report, re-election of directors, and approval of the company’s equity incentive plan. These decisions reflect strong shareholder support and are likely to positively impact the company’s strategic initiatives and operational growth.
The most recent analyst rating on (AU:VFY) stock is a Buy with a A$2.10 price target. To see the full list of analyst forecasts on Vitrafy Life Sciences Ltd. stock, see the AU:VFY Stock Forecast page.
More about Vitrafy Life Sciences Ltd.
Vitrafy Life Sciences Limited is a company specializing in advanced cryopreservation technology, significantly enhancing cell survival rates for applications such as blood platelets, cell and gene therapies, aquaculture, and bovine reproduction. The company offers comprehensive cryopreservation solutions through a managed service model, utilizing FDA-registered devices and integrated software platforms.
Average Trading Volume: 25,959
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$97.05M
Learn more about VFY stock on TipRanks’ Stock Analysis page.